Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilus Influenzae Type b Immunisation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01251133
What this trial is testing

Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study

Who this might be right for
Infectious Disease by Haemophilus Influenzae Type b
LG Life Sciences 122
Large-scale testing (Phase 3)Study completedNCT00345579
What this trial is testing

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 4,432
Large-scale testing (Phase 3)Study completedNCT00291343
What this trial is testing

Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 296
Post-approval studies (Phase 4)UnknownNCT02179996
What this trial is testing

Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born Neonates

Who this might be right for
Hib Immunisation in Very Preterm-born InfantsPertussis Immunisation in Very Preterm-born Infants
Central Hospital, Nancy, France 160
Not applicableStudy completedNCT01878435
What this trial is testing

Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Johns Hopkins Bloomberg School of Public Health 2,018
Large-scale testing (Phase 3)Study completedNCT00169442
What this trial is testing

Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants

Who this might be right for
Whole Cell PertussisDiphtheriaHepatitis B+2 more
GlaxoSmithKline 745
Not applicableUnknownNCT00932269
What this trial is testing

Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease

Who this might be right for
DiphtheriaTetanusPertussis+6 more
Swedish Institute for Infectious Disease Control 5,400
Large-scale testing (Phase 3)Study completedNCT00355654
What this trial is testing

Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar®

Who this might be right for
InfantHealthy
Sanofi Pasteur, a Sanofi Company 847
Large-scale testing (Phase 3)Study completedNCT00317122
What this trial is testing

Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth

Who this might be right for
Diphtheria; Haemophilus Influenzae Type b; Hepatitis B; Tetanus; Whole Cell Pertussis
GlaxoSmithKline 192
Large-scale testing (Phase 3)Study completedNCT00289783
What this trial is testing

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 4,441
Large-scale testing (Phase 3)Study completedNCT01449812
What this trial is testing

Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine

Who this might be right for
Acellular PertussisTetanusDiphtheria+1 more
GlaxoSmithKline 831
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Testing effectiveness (Phase 2)Study completedNCT00129116
What this trial is testing

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 388
Testing effectiveness (Phase 2)Ended earlyNCT00871741
What this trial is testing

Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.

Who this might be right for
TetanusPoliomyelitisNeisseria Meningitidis+4 more
GlaxoSmithKline 16
Large-scale testing (Phase 3)Study completedNCT00259337
What this trial is testing

Immunogenicity and Safety of Pentaxim™ in an Indian Population

Who this might be right for
DiphtheriaTetanusPolio+2 more
Sanofi 226
Testing effectiveness (Phase 2)Study completedNCT01248884
What this trial is testing

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

Who this might be right for
TetanusPoliomyelitisHepatitis B+3 more
GlaxoSmithKline 721
Post-approval studies (Phase 4)Study completedNCT01457547
What this trial is testing

Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course

Who this might be right for
Hepatitis BPoliomyelitisDiphtheria+3 more
GlaxoSmithKline 494
Testing effectiveness (Phase 2)Study completedNCT00129129
What this trial is testing

Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 756
Testing effectiveness (Phase 2)Study completedNCT00127855
What this trial is testing

Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 409
Large-scale testing (Phase 3)Study completedNCT01062477
What this trial is testing

DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi 1,056
Next Page